- Home
- SNT vs RPTX Comparison
SNT vs RPTX Comparison
Compare SNT & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNT | RPTX |
|---|---|---|
| Founded | 1965 | 2016 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.2M | 92.4M |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNT | RPTX |
|---|---|---|
| Price | $4.45 | $2.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 67.1K | ★ 1.3M |
| Earning Date | 11-25-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 257.88 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $37,837,000.00 | $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,122.22 |
| P/E Ratio | $21.38 | ★ N/A |
| Revenue Growth | ★ 9.82 | N/A |
| 52 Week Low | $2.57 | $0.89 |
| 52 Week High | $5.34 | $2.66 |
Technical Indicators
Market Signals| Indicator | SNT | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 65.39 | 74.94 |
| Support Level | $3.10 | $2.15 |
| Resistance Level | $4.29 | $2.66 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 96.68 | 83.96 |
Price Performance
Historical ComparisonAbout SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.